Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-07
1992-11-10
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 80, 514 86, 5142222, 5142265, 5142268, 5142278, 5142282, 5142288, 5142322, 2522325, 2522358, 2522365, 252253, 252269, 252274, 544 3, 544 54, 544 55, 544 57, 544 586, 544 60, 544 62, 544 63, 544 80, 544 82, 544 96, 544116, A61K 31505, C07D40110, C07D40112, C07D27904
Patent
active
051623250
ABSTRACT:
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists. ##STR1##
Chakravarty Prasun K.
Maccoss Malcolm
Mantlo Nathan
Walsh Thomas F.
Camara Valerie J.
DiPrima Joseph F.
Gupta Y. N.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Angiotensin II antagonists incorporating a substituted benzyl el does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonists incorporating a substituted benzyl el, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonists incorporating a substituted benzyl el will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2292858